9 Ways to Pay for Ozempic in 2026: Real Costs by Pathway

What is Ozempic actually — and why does the price vary so much?

Ozempic is semaglutide — a GLP-1 receptor agonist manufactured by Novo Nordisk. It was FDA-approved in 2017 for adults with type 2 diabetes to improve blood sugar control and reduce the risk of major cardiovascular events. That FDA approval is key: every insurance coverage decision, savings card, and prior-authorization rule flows from what Ozempic is officially approved to treat.

In 2026, the product expanded. Novo Nordisk received FDA approval for Ozempic tablets (1.5 mg, 4 mg, and 9 mg). To be precise, this is not the first oral semaglutide for type 2 diabetes — that was Rybelsus, approved back in 2019. The 2026 Ozempic tablet is essentially a reformulation and rebrand of oral semaglutide under the Ozempic name, at higher tablet strengths. This is what people searching for 'oral Ozempic' are asking about. At the same time, Wegovy (a higher-dose semaglutide pen) and its oral counterpart carry the FDA indication for chronic weight management in adults without diabetes.

The reason the price varies so wildly — from $25 to over $1,000 a month — is that your cost depends on four things: your insurance coverage, your diagnosis, which savings program you access, and whether you're using brand-name Ozempic or a compounded semaglutide alternative. The sections below walk through each pathway.

Ozempic vs. Wegovy: same molecule, very different coverage (this is the part that trips people up)

Ozempic and Wegovy both contain semaglutide. They are not the same product to your insurance company.

• Ozempic pen: approved for type 2 diabetes. Most commercial insurance plans cover it when prescribed for T2D. Many do not cover it for weight loss.
• Wegovy pen: approved for chronic weight management (obesity or overweight with a comorbidity). Coverage is more variable — some plans cover it, many still exclude it.
• Ozempic pill (new in 2026): approved for type 2 diabetes. Same coverage rules as the Ozempic pen.
• Wegovy pill (oral semaglutide, 2026): approved for chronic weight management. Cash price launched at $149-$199/mo; insurance coverage is still rolling out.

For women in perimenopause or menopause who want to use semaglutide for weight management but do not have a type 2 diabetes diagnosis, the path is different. A provider may prescribe Ozempic off-label for weight loss, but insurance is unlikely to cover it in that scenario. Wegovy — or compounded semaglutide — is usually the more realistic route to affordability. The GLP-1 cost overview covers how each molecule compares across indications.

How much does Ozempic cost with commercial insurance?

This is the best-case scenario for most people. If you have a T2D diagnosis and commercial insurance that covers Ozempic, the NovoCare Savings Card brings your monthly copay down to as little as $25 per month. The card covers up to $100 in copay savings per 30-day supply (or $200 per 60-day supply).

In practice, your actual copay lands between $25 and $150 per month, depending on how your plan has tiered Ozempic. Many plans list it as a specialty Tier 3 or Tier 4 drug. When the NovoCare card is applied on top, most commercially insured T2D patients end up in the $0-$50 range per month.

• Eligible: US residents with commercial insurance who have a valid Ozempic prescription (any approved T2D use)
• Not eligible: Medicare, Medicaid, TRICARE, or any government health program
• Enrollment: at novocare.com — no income requirement, no waiting period
• Cap: up to $100 per 30-day supply — if your copay is higher, you pay the difference

Ozempic cost without insurance: the NovoCare self-pay program

In 2024, Novo Nordisk launched a self-pay pricing program so that uninsured patients — or patients whose insurance doesn't cover Ozempic — have a direct route to the medication at lower than retail. Introductory pricing runs through December 31, 2026.

• First 2 monthly fills (0.25mg or 0.5mg starter doses): $199/mo — introductory rate for new patients
• Maintenance dose, <=1mg pen: $349/mo
• Maintenance dose, 2mg pen: $499/mo
• Oral Ozempic pill, 1.5mg: $149/mo
• Oral Ozempic pill, 4mg: $199/mo (offer through Aug 31, 2026)
• Oral Ozempic pill, 9mg: $299/mo

One critical caveat: amounts paid under this program don't count toward your insurance deductible or out-of-pocket maximum, and the cost cannot be submitted for insurance reimbursement later. If you're close to meeting a deductible, run the math both ways.

At $349/mo maintenance, the annual cost of the Ozempic pen under the self-pay program is approximately $4,188/yr. At $499/mo for the 2mg dose, that climbs to roughly $5,988/yr.

The new oral Ozempic pill: what it costs and who it's for

In 2026, Ozempic tablets became available at US pharmacies. They are not the first oral semaglutide for type 2 diabetes — Rybelsus has held that indication since 2019 — but rather a higher-strength reformulation of oral semaglutide carrying the Ozempic brand. The pill is not approved for weight loss (that's the Wegovy pill, a separate product), and it works differently from the injection: the tablet form requires specific administration conditions (fasting, 30 minutes before the first meal, taken with a small amount of water).

For those who meet the T2D indication and prefer not to inject, the self-pay pricing is notably lower than the pen: $149/mo for the 1.5mg dose and $199/mo for the 4mg dose through NovoCare. That makes the oral Ozempic pill roughly $150-$200 per month cheaper than the pen at maintenance pricing — a meaningful difference at scale.

Insurance coverage for the pill is still rolling out. Commercially insured T2D patients should confirm formulary status with their plan before assuming coverage applies.

Costco pharmacy Ozempic price: what members actually pay

Costco entered the GLP-1 market through a partnership that lets members fill brand-name Ozempic and Wegovy prescriptions through the Costco Member Prescription Program. Pricing for Costco members aligns with the NovoCare self-pay tiers: approximately $349/mo for doses up to 1mg and $499/mo for the 2mg pen.

New patients can access the same $199/mo introductory pricing through participating programs. A valid prescription and Costco membership are required. Members with an Executive membership may receive an additional benefit. Price varies by location — confirm at your local Costco pharmacy before assuming a specific number.

GoodRx coupon for Ozempic: how the math actually works

GoodRx is not a prescription benefit — it's a discount card you present at the pharmacy instead of your insurance. For Ozempic, GoodRx partnered with Novo Nordisk to match the self-pay pricing: new GoodRx users can access the $199/mo introductory rate for the first two fills at starter doses, then $349/mo for the <=1mg pen.

Without that partnership pricing, the raw GoodRx coupon pulls Ozempic's list price from $1,028-$1,100/mo down to roughly the $950-$1,020 range at most major chains — useful, but not as low as the NovoCare/self-pay programs. If you're comparing, start with the NovoCare program directly: you may not need a third-party intermediary.

Compounded semaglutide: the lowest-cost pathway — and what to understand first

Compounded semaglutide is a different product from brand-name Ozempic. It's made by licensed 503A compounding pharmacies and is not FDA-approved. Through 2024 and 2025, compounded semaglutide was broadly available because Ozempic was on the FDA drug shortage list. As of early 2026, FDA removed semaglutide from the shortage list, which means compounding pharmacies can no longer legally make copies of the branded product at scale — but 503A pharmacies may still compound it for individual patients with a valid prescription and documented clinical need. Telehealth providers are navigating this shifting landscape differently. Verify current availability directly with any provider before signing up.

Cost-wise, compounded semaglutide programs run $150-$249/mo — roughly a third of the brand-name self-pay price. Three providers our team has reviewed:

Fridays — Best for budget-conscious, long-term users

Fridays charges $199/mo month-to-month for compounded semaglutide injection, dropping to $150/mo on a prepaid annual plan ($1,800 billed upfront). The flat fee includes provider visits, dietitian coaching, group sessions, and a fitness app — no separate membership or lab fees. At $150/mo annually, the annual cost is $1,800/yr, versus $4,188/yr on NovoCare self-pay at 1mg. Read our full Fridays review.

Mochi Health — Best for clinical support at a predictable price

Mochi Health prices the medication and the membership separately, which keeps things transparent: $79/mo membership plus $99/mo for compounded semaglutide at any dose, totaling $178/mo all-in. The membership covers provider visits, dietitian access, and ongoing messaging. At $178/mo, the annual cost is approximately $2,136/yr. Read our full Mochi Health review.

Henry Meds — Best for flexibility between injectable and oral compounded options

Henry Meds offers compounded injectable semaglutide starting at $149/mo for the first month, then $247/mo on a 12-month plan. A compounded oral semaglutide option is also available at $249/mo. The injectable plan's annual cost on the 12-month rate works out to roughly $2,964/yr. Read our full Henry Meds review.

Does Medicare cover Ozempic?

Medicare Part D covers Ozempic when it's prescribed for type 2 diabetes. Coverage for weight loss alone is not available through Medicare for Ozempic specifically. Federal law has historically barred Part D from covering drugs prescribed solely for weight loss.

Two important 2026 updates for Medicare beneficiaries:

• Wegovy (not Ozempic) received expanded Medicare coverage after the SELECT cardiovascular outcomes trial showed semaglutide reduced major cardiovascular events in patients with obesity and established heart disease. Eligible beneficiaries — those with prior heart attack, stroke, or peripheral arterial disease plus a qualifying BMI — can access Wegovy under Part D for cardiovascular risk reduction.
• Starting July 1, 2026, a Medicare GLP-1 Bridge program covers certain GLP-1s (Wegovy and Zepbound) for weight loss at a $50/mo copay for eligible Part D members. Ozempic and Mounjaro (the diabetes-branded versions) are not included.
• Out-of-pocket costs for those who do get Part D coverage for Ozempic are capped. Medicare Part D's $2,000 annual out-of-pocket cap means most patients won't pay more than $2,000/yr in drug costs even for a high-cost medication.

What does Ozempic cost per year — the full math

Running the numbers across every pathway makes the gaps concrete:

• Retail price, no savings: ~$12,336-$13,200/yr ($1,028-$1,100/mo x 12)
• Commercial insurance + NovoCare card: ~$300-$600/yr ($25-$50/mo x 12)
• NovoCare self-pay, 1mg pen: ~$4,188/yr ($349/mo x 12)
• NovoCare self-pay, 2mg pen: ~$5,988/yr ($499/mo x 12)
• Oral Ozempic pill self-pay, 1.5mg: ~$1,788/yr ($149/mo x 12)
• Oral Ozempic pill self-pay, 4mg: ~$2,388/yr ($199/mo x 12)
• Fridays compounded (annual plan): ~$1,800/yr ($150/mo x 12)
• Mochi Health compounded: ~$2,136/yr ($178/mo x 12)
• Henry Meds compounded (12-mo plan): ~$2,964/yr ($247/mo x 12)
• Medicare Part D (T2D indication): capped at $2,000/yr out-of-pocket maximum

The oral Ozempic pill's self-pay pricing at $149-$199/mo makes it the most affordable brand-name semaglutide option for uninsured T2D patients — even cheaper than most compounded programs. For women using semaglutide off-label for weight management without a T2D diagnosis, compounded pathways through telehealth remain the lowest-cost entry point, though the shifting legal landscape around compounding is worth watching.

What if your insurance denies Ozempic for weight loss?

Denials for off-label weight loss use are common — and expected. Most commercial plans will cover Ozempic for type 2 diabetes but deny claims when the sole indication is weight management. If you receive a denial, you have several practical options.

• Appeal: A meaningful share of insurance denials are overturned when appealed. Your provider can submit documentation of medical necessity. Most insurers allow appeals within 30-180 days of denial.
• Switch to Wegovy: If your provider thinks semaglutide is appropriate for weight management, Wegovy carries the weight-loss indication. Some plans that deny Ozempic for weight loss will cover Wegovy — check your formulary.
• Ask about the NovoCare self-pay program: If coverage isn't going to work, the self-pay intro rate of $199/mo buys time while you appeal or explore alternatives.
• Consider compounded semaglutide: Subject to current FDA guidance on compounding status, telehealth providers like Fridays, Mochi Health, and Henry Meds offer semaglutide at $150-$247/mo without insurance.

How to choose your Ozempic cost pathway

The right choice depends on three factors: your diagnosis, your insurance, and how long you plan to stay on the medication.

• T2D diagnosis + commercial insurance: Start with NovoCare savings card. Monthly cost is typically $0-$50 after the card is applied.
• T2D diagnosis, no insurance: Try the oral Ozempic pill first ($149-$199/mo self-pay) before defaulting to the pen ($349/mo+). The pill's self-pay pricing beats the pen.
• Weight management goal, no T2D, no insurance: Compounded semaglutide through a telehealth provider is the most realistic price point. Understand the FDA status before signing up.
• Medicare beneficiary: Confirm whether your Part D plan covers Ozempic for T2D. If you also have cardiovascular disease history, ask about Wegovy coverage under the cardiovascular indication.
• Considering Costco: Costco pharmacy prices match NovoCare self-pay tiers. The convenience is real; the savings over using NovoCare directly are minimal. Membership is required.